Table 1.
# | Substrate | IC50 (nm) | Reference |
---|---|---|---|
11 | Ac-pTyr-Leu-Pro-Gln-Val- NH2 |
739 ± 31 | Coleman et al. 2005 |
12 | Ac-pTyr-Leu-mPro-Gln-Val- NH2 |
265 ± 14a | Coleman et al. 2005 |
13 | pCinn-Leu-Pro-Gln-NHBn | 138 ± 8 | Mandal et al. 2009b |
14 | pCinn-Leu-mPro-Gln-NHBn | 68 ± 8 | Mandal et al. 2009b |
15 |
βMpCinn-Leu-Pro-Gln- NHBn |
70 ± 15 | Mandal et al. 2011 |
16 |
βMpCinn-Leu-mPro-Gln- NHBn |
46 ± 5 | Mandal et al. 2011 |
17 | βMpCinn-Leu-Pro-Apa | 154 ± 10 | Mandal et al. 2011 |
18 | βMpCinn-Leu-mPro-Apa | 88 ± 11 | Mandal et al. 2011 |
pCinn 4-phosphoryloxycinnamoyl, βMpCinn 4-phosphoryloxy-β-methylcinnamoyl, Apa (R)-4-aminopentamide
Commercially available mPro is a racemic mixture of enantiomers. Only the more active diastereomer was reported